Merck Insomnia Drug Safe Only in Lower Doses, Panel Says

Merck & Co.’s experimental insomnia drug, meant to be a less disruptive alternative to Sanofi’s Ambien sleeping pill, is safe only at lower doses, U.S. regulatory advisers said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.